XML 63 R53.htm IDEA: XBRL DOCUMENT v3.4.0.3
Integration and acquisition costs (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Business Acquisition [Line Items]    
Integration and acquisition costs $ 91.1 $ 75.7
Contingent consideration payments (2.1) (2.4)
Dyax and proposed combination with Baxalta    
Business Acquisition [Line Items]    
Integration and acquisition costs $ 91.1  
NPS Pharma    
Business Acquisition [Line Items]    
Integration and acquisition costs   $ 75.7